In vitro hematopoietic and endothelial potential of flk-1(−/−) embryonic stem cells and embryos

por Schuh, Andre C., Faloon, Patrick, Hu, Qing-Long, Bhimani, Munsif, Choi, Kyunghee
Publicado em 1999

Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab

por Topp, Max S., Zimmerman, Zachary, Cannell, Paul, Dombret, Hervé, Maertens, Johan, Stein, Anthony, Franklin, Janet, Tran, Qui, Cong, Ze, Schuh, Andre C.
Publicado no Blood (2018)

Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia

por Stein, Anthony S., Larson, Richard A., Schuh, Andre C., Stevenson, William, Lech-Maranda, Ewa, Tran, Qui, Zimmerman, Zachary, Kormany, William, Topp, Max S.
Publicado no Blood Adv (2018)

Treatment of older patients with acute myeloid leukemia (AML): revised Canadian consensus guidelines

por Brandwein, Joseph M, Zhu, Nancy, Kumar, Rajat, Leber, Brian, Sabloff, Mitchell, Sandhu, Irwindeep, Kassis, Jeannine, Olney, Harold J, Elemary, Mohamed, Schuh, Andre C
Publicado no Am J Blood Res (2017)

Consensus Recommendations for MRD Testing in Adult B-Cell Acute Lymphoblastic Leukemia in Ontario

por Tierens, Anne, Stockley, Tracy L., Campbell, Clinton, Fulcher, Jill, Leber, Brian, McCready, Elizabeth, Sabatini, Peter J. B., Sadikovic, Bekim, Schuh, Andre C.
Publicado no Curr Oncol (2021)

Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensus

por Brandwein, Joseph M, Geddes, Michelle, Kassis, Jeannine, Kew, Andrea K, Leber, Brian, Nevill, Thomas, Sabloff, Mitchell, Sandhu, Irwindeep, Schuh, Andre C, Storring, John M, Ashkenas, John
Publicado em 2013

A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia

por Reed, Gregory A., Schiller, Gary J., Kambhampati, Suman, Tallman, Martin S., Douer, Dan, Minden, Mark D., Yee, Karen W., Gupta, Vikas, Brandwein, Joseph, Jitkova, Yulia, Gronda, Marcela, Hurren, Rose, Shamas‐Din, Aisha, Schuh, Andre C., Schimmer, Aaron D.
Publicado no Cancer Med (2016)

Measurable residual disease monitoring provides insufficient lead-time to prevent morphological relapse in the majority of patients with core-binding factor acute myeloid leukemia

por Puckrin, Robert, Atenafu, Eshetu G., Claudio, Jaime O., Chan, Steven, Gupta, Vikas, Maze, Dawn, McNamara, Caroline, Murphy, Tracy, Schuh, Andre C., Yee, Karen, Sibai, Hassan, Minden, Mark D., Wei, Cuihong, Stockley, Tracy, Kamel-Reid, Suzanne, Schimmer, Aaron D.
Publicado no Haematologica (2020)

Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL Regimen

por Chen, Ruiqi, Liu, Xing, Law, Arjun D., Kanfar, Solaf, Maze, Dawn, Chan, Steven M., Gupta, Vikas, Yee, Karen W., Minden, Mark D., Schimmer, Aaron D., Schuh, Andre C., McNamara, Caroline J., Murphy, Tracy, Xu, Anna, Falcone, Umberto, Seki, Jack, Sibai, Hassan
Publicado no Curr Oncol (2020)

Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML

por Murphy, Tracy, Zou, Jinfeng, Daher-Reyes, Georgina S., Arruda, Andrea, Gupta, Vikas, McNamara, Caroline J., Minden, Mark D., Schimmer, Aaron D., Sibai, Hassan, Yee, Karen W. L., Korulla, Mariam, Stockley, Tracy, Kamel-Reid, Suzanne, Maze, Dawn, Tierens, Anne, Bratman, Scott V., Schuh, Andre C., Chan, Steven M.
Publicado no Blood Adv (2019)

Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells

por Carter, Bing Z., Gronda, Marcela, Wang, Zhiliang, Welsh, Kate, Pinilla, Clemencia, Andreeff, Michael, Schober, Wendy D., Nefzi, Adel, Pond, Gregory R., Mawji, Imtiaz A., Houghten, Richard A., Ostresh, John, Brandwein, Joseph, Minden, Mark D., Schuh, Andre C., Wells, Richard A., Messner, Hans, Chun, Kathy, Reed, John C., Schimmer, Aaron D.
Publicado em 2005

Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens

por Seymour, John F., Döhner, Hartmut, Butrym, Aleksandra, Wierzbowska, Agnieszka, Selleslag, Dominik, Jang, Jun Ho, Kumar, Rajat, Cavenagh, James, Schuh, Andre C., Candoni, Anna, Récher, Christian, Sandhu, Irwindeep, del Castillo, Teresa Bernal, Al-Ali, Haifa Kathrin, Falantes, Jose, Stone, Richard M., Minden, Mark D., Weaver, Jerry, Songer, Steve, Beach, C. L., Dombret, Hervé
Publicado no BMC Cancer (2017)

A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia

por How, Jonathan, Minden, Mark D., Brian, Leber, Chen, Eric X., Brandwein, Joseph, Schuh, Andre C., Schimmer, Aaron D., Gupta, Vikas, Webster, Sheila, Degelder, Tammy, Haines, Patricia, Stayner, Lee-Anne, McGill, Shauna, Wang, Lisa, Piekarz, Richard, Wong, Tracy, Siu, Lillian L., Espinoza-Delgado, Igor, Holleran, Julianne L., Egorin, Merrill J., Yee, Karen W. L.
Publicado no Leuk Lymphoma (2015)

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

por Kantarjian, Hagop, Stein, Anthony, Gökbuget, Nicola, Fielding, Adele K., Schuh, Andre C., Ribera, Josep-Maria, Wei, Andrew, Dombret, Hervé, Foà, Robin, Bassan, Renato, Arslan, Önder, Sanz, Miguel A., Bergeron, Julie, Demirkan, Fatih, Lech-Maranda, Ewa, Rambaldi, Alessandro, Thomas, Xavier, Horst, Heinz-August, Brüggemann, Monika, Klapper, Wolfram, Wood, Brent L., Fleishman, Alex, Nagorsen, Dirk, Holland, Christopher, Zimmerman, Zachary, Topp, Max S.
Publicado no N Engl J Med (2017)

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

por Dombret, Hervé, Seymour, John F., Butrym, Aleksandra, Wierzbowska, Agnieszka, Selleslag, Dominik, Jang, Jun Ho, Kumar, Rajat, Cavenagh, James, Schuh, Andre C., Candoni, Anna, Récher, Christian, Sandhu, Irwindeep, Bernal del Castillo, Teresa, Al-Ali, Haifa Kathrin, Martinelli, Giovanni, Falantes, Jose, Noppeney, Richard, Stone, Richard M., Minden, Mark D., McIntyre, Heidi, Songer, Steve, Lucy, Lela M., Beach, C. L., Döhner, Hartmut
Publicado no Blood (2015)

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Aust...

por Pleyer, Lisa, Döhner, Hartmut, Dombret, Hervé, Seymour, John F., Schuh, Andre C., Beach, CL, Swern, Arlene S., Burgstaller, Sonja, Stauder, Reinhard, Girschikofsky, Michael, Sill, Heinz, Schlick, Konstantin, Thaler, Josef, Halter, Britta, Machherndl Spandl, Sigrid, Zebisch, Armin, Pichler, Angelika, Pfeilstöcker, Michael, Autzinger, Eva M., Lang, Alois, Geissler, Klaus, Voskova, Daniela, Sperr, Wolfgang R., Hojas, Sabine, Rogulj, Inga M., Andel, Johannes, Greil, Richard
Publicado no Int J Mol Sci (2017)

Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia

por DiNardo, Courtney D., Stein, Anthony S., Stein, Eytan M., Fathi, Amir T., Frankfurt, Olga, Schuh, Andre C., Döhner, Hartmut, Martinelli, Giovanni, Patel, Prapti A., Raffoux, Emmanuel, Tan, Peter, Zeidan, Amer M., de Botton, Stéphane, Kantarjian, Hagop M., Stone, Richard M., Frattini, Mark G., Lersch, Frederik, Gong, Jing, Gianolio, Diego A., Zhang, Vickie, Franovic, Aleksandra, Fan, Bin, Goldwasser, Meredith, Daigle, Scott, Choe, Sung, Wu, Bin, Winkler, Thomas, Vyas, Paresh
Publicado no J Clin Oncol (2021)

Identification of pre-leukemic hematopoietic stem cells in acute leukemia

por Shlush, Liran I., Zandi, Sasan, Mitchell, Amanda, Chen, Weihsu Claire, Brandwein, Joseph M., Gupta, Vikas, Kennedy, James A., Schimmer, Aaron D., Schuh, Andre C., Yee, Karen W., McLeod, Jessica L., Doedens, Monica, Medeiros, Jessie J.F., Marke, Rene, Kim, Hyeoung Joon, Lee, Kwon, McPherson, John D., Hudson, Thomas J., Brown, Andrew M.K., Trinh, Quang M., Stein, Lincoln D., Minden, Mark D., Wang, Jean C.Y., Dick, John E.
Publicado no Nature (2014)

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

por Zeidan, Amer M, Boddu, Prajwal C, Patnaik, Mrinal M, Bewersdorf, Jan Philipp, Stahl, Maximilian, Rampal, Raajit K, Shallis, Rory, Steensma, David P, Savona, Michael R, Sekeres, Mikkael A, Roboz, Gail J, DeAngelo, Daniel J, Schuh, Andre C, Padron, Eric, Zeidner, Joshua F, Walter, Roland B, Onida, Francesco, Fathi, Amir, DeZern, Amy, Hobbs, Gabriela, Stein, Eytan M, Vyas, Paresh, Wei, Andrew H, Bowen, David T, Montesinos, Pau, Griffiths, Elizabeth A, Verma, Amit K, Keyzner, Alla, Bar-Natan, Michal, Navada, Shyamala C, Kremyanskaya, Marina, Goldberg, Aaron D, Al-Kali, Aref, Heaney, Mark L, Nazha, Aziz, Salman, Huda, Luger, Selina, Pratz, Keith W, Konig, Heiko, Komrokji, Rami, Deininger, Michael, Cirici, Blanca Xicoy, Bhatt, Vijaya Raj, Silverman, Lewis R, Erba, Harry P, Fenaux, Pierre, Platzbecker, Uwe, Santini, Valeria, Wang, Eunice S, Tallman, Martin S, Stone, Richard M, Mascarenhas, John
Publicado no Lancet Haematol (2020)